Does RESLIZUMAB Cause Incorrect dose administered? 63 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Incorrect dose administered have been filed in association with RESLIZUMAB (CINQAIR). This represents 10.1% of all adverse event reports for RESLIZUMAB.
63
Reports of Incorrect dose administered with RESLIZUMAB
10.1%
of all RESLIZUMAB reports
1
Deaths
11
Hospitalizations
How Dangerous Is Incorrect dose administered From RESLIZUMAB?
Of the 63 reports, 1 (1.6%) resulted in death, 11 (17.5%) required hospitalization.
Is Incorrect dose administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RESLIZUMAB. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does RESLIZUMAB Cause?
Dyspnoea (86)
Asthma (82)
Drug ineffective (80)
Hypertension (47)
Headache (41)
Wheezing (40)
Cough (36)
Oropharyngeal pain (31)
Fatigue (29)
Myalgia (29)
What Other Drugs Cause Incorrect dose administered?
TIRZEPATIDE (23,301)
ADALIMUMAB (14,000)
DUPILUMAB (9,907)
RANITIDINE (9,337)
INSULIN LISPRO (8,318)
ACETAMINOPHEN (5,316)
DULAGLUTIDE (5,207)
SECUKINUMAB (4,524)
INSULIN GLARGINE (3,070)
SOMATROPIN (2,772)
Which RESLIZUMAB Alternatives Have Lower Incorrect dose administered Risk?
RESLIZUMAB vs RESMETIROM
RESLIZUMAB vs RESTASIS
RESLIZUMAB vs RETINOL
RESLIZUMAB vs REVATIO
RESLIZUMAB vs REVEFENACIN